Adam R, de Gramont A, Figueras J, Kokudo N, Kunstlinger F, Loyer E, Poston G, Rougier P, Rubbia-Brandt L, Sobrero A, Teh C, Tejpar S, Van Cutsem E, Vauthey J-N, Påhlman L. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. Cancer Treat Rev. 2015;41(9):729–41. https://doi.org/10.1016/j.ctrv.2015.06.006.

Article  Google Scholar 

Ali SM, Pawlik TM, Rodriguez-Bigas MA, Monson JRT, Chang GJ, Larson DW. Timing of surgical resection for curative colorectal cancer with liver metastasis. Ann Surg Oncol. 2018;25(1):32–7. https://doi.org/10.1245/s10434-016-5745-7.

Article  Google Scholar 

Biller LH, Schrag D. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA. 2021;325(7):669–85. https://doi.org/10.1001/jama.2021.0106.

CAS  Article  Google Scholar 

•• Boudjema K, Locher C, Sabbagh C, Ortega-Deballon P, Heyd B, Bachellier P, Métairie S, Paye F, Bourlier P, Adam R, Merdrignac A, Tual C, Le Pabic E, Sulpice L, Meunier B, Regimbeau J-M, Bellissant E, group MS. Simultaneous versus delayed resection for initially resectable synchronous colorectal cancer liver metastases: a prospective, open-label, randomized, controlled trial. Ann Surg. 2021;273(1):49–56. https://doi.org/10.1097/SLA.0000000000003848. This novel randomized control study looked at complication rates between synchronous and delayed resection. They found that complication rates did not appear to differ when colorectal cancer and simultaneous liver metastases are resected simultaneously.

• Chauhan N, Mulcahy MF, Salem R, Benson Iii AB, Boucher E, Bukovcan J, Cosgrove D, Laframboise C, Lewandowski RJ, Master F, El-Rayes B, Strosberg JR, Sze DY, Sharma RA. TheraSphere yttrium-90 glass microspheres combined with chemotherapy versus chemotherapy alone in second-line treatment of patients with metastatic colorectal carcinoma of the liver: protocol for the EPOCH phase 3 randomized clinical trial. JMIR Res Protoc. 2019 Jan 17;8(1):e11545. https://doi.org/10.2196/11545. Ongoing study to evaluate the role of combination therapy with TARE and oxaliplatin- or irinotecan-based chemotherapy in the second-line treatment of metastatic colorectal cancer of the liver.

Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, Lillemoe KD, Yeo CJ, Cameron JL. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg. 2002;235(6):759–66. https://doi.org/10.1097/00000658-200206000-00002.

Article  Google Scholar 

Coco D, Leanza S. Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) in colorectal liver metastases: review of the literature. Clin Exp Hepatol. 2021;7(2):125–33. https://doi.org/10.5114/ceh.2021.106521.

Article  Google Scholar 

DʼAngelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N. Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes. Ann Surg. 2015 Feb;261(2):353–60. https://doi.org/10.1097/SLA.0000000000000614.

Engstrand J, Nilsson H, Strömberg C, Jonas E, Freedman J. Colorectal cancer liver metastases - a population-based study on incidence, management and survival. BMC Cancer. 2018;18(1):78. https://doi.org/10.1186/s12885-017-3925-x.

Article  Google Scholar 

•• Ejaz A, Semenov E, Spolverato G, Kim Y, Tanner D, Hundt J, Pawlik TM. Synchronous primary colorectal and liver metastasis: impact of operative approach on clinical outcomes and hospital charges. HPB (Oxford). 2014 Dec;16(12):1117–26. https://doi.org/10.1111/hpb.12302. Study found that patients with synchronous liver metastases managed with either simultaneous or staged surgery have comparable perioperative and long-term outcomes.

European Organization for R, Treatment of Cancer E. Randomized phase II trial evaluating the efficacy of FOLFOX alone, FOLFOX plus bevacizumab and FOLFOX plus panitumumab as perioperative treatment in patients with resectable liver metastases from wild type KRAS/NRAS colorectal cancer. Clinical trial registration. clinicaltrials.gov, 2016 2016/10/11/. Report No.: NCT01508000.

Fiorentini G, Aliberti C, Tilli M, Mulazzani L, Graziano F, Giordani P, Mambrini A, Montagnani F, Alessandroni P, Catalano V, Coschiera P. Intra-arterial infusion of irinotecan-loaded drug-eluting beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: final results of a phase III study. Anticancer Res. 2012;32(4):1387–95.

CAS  Google Scholar 

Herrero A, Nadalin S, Panaro F. Liver transplantation for irresectable colorectal liver metastases: still a contraindication? Hepatobiliary Surg Nutr. 2018 Dec;7(6):475–478. https://doi.org/10.21037/hbsn.2018.08.04.

Jessup JM, Goldberg RM, et al. Colon and rectum. In: Amin MB, Edge SB, Greene FL, et al., editors. AJCC cancer staging manual. 8th ed. New York: Springer; 2017. p. 251–74.

Chapter  Google Scholar 

Maher B, Ryan E, Little M, Boardman P, Stedman B. The management of colorectal liver metastases. Clin Radiol. 2017;72(8):617–25. https://doi.org/10.1016/j.crad.2017.05.016.

CAS  Article  Google Scholar 

Martin RCG, Scoggins CR, Schreeder M, Rilling WS, Laing CJ, Tatum CM, Kelly LR, Garcia-Monaco RD, Sharma VR, Crocenzi TS, Strasberg SM. Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis. Cancer. 2015;121(20):3649–58. https://doi.org/10.1002/cncr.29534.

CAS  Article  Google Scholar 

Puia-Negulescu S, Lebossé F, Mabrut JY, Muller X, Rossignol G, Antonini T, Erard D, Radenne S, Guillet M, Souquet JC, Mohkam K, Lesurtel M. Liver transplantation for colorectal liver metastases: current management and future perspectives. Int J Mol Sci. 2021;22(6):3093. https://doi.org/10.3390/ijms22063093.

Article  Google Scholar 

Riihimäki M, Hemminki A, Sundquist J, Hemminki K. Patterns of metastasis in colon and rectal cancer. Sci Rep. 2016;15(6):29765. https://doi.org/10.1038/srep29765.

CAS  Article  Google Scholar 

Ruers T, Van Coevorden F, Punt CJA, Pierie J-PEN, Borel-Rinkes I, Ledermann JA, Poston G, Bechstein W, Lentz M-A, Mauer M, Folprecht G, Van Cutsem E, Ducreux M, Nordlinger B, European Organisation for R, Treatment of C, Gastro-Intestinal Tract Cancer G, Arbeitsgruppe Lebermetastasen und tumoren in der Chirurgischen Arbeitsgemeinschaft O, National Cancer Research Institute Colorectal Clinical Study G. Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial. J Natl Cancer Inst. 2017;109(9). https://doi.org/10.1093/jnci/djx015.

Smith JJ, D’Angelica MI. Surgical management of hepatic metastases of colorectal cancer. Hematol Oncol Clin North Am. 2015;29(1):61–84. https://doi.org/10.1016/j.hoc.2014.09.003.

Article  Google Scholar 

Sturesson C, Nilsson J, Lindell G, Andersson RG, Keussen I. Disappearing liver metastases from colorectal cancer: impact of modern imaging modalities. HPB (Oxford). 2015;17(11):983–7. https://doi.org/10.1111/hpb.12476.

Article  Google Scholar 

Tanaka K, Shimada H, Matsuo K, Nagano Y, Endo I, Sekido H, Togo S. Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases. Surgery. 2004;136(3):650–9. https://doi.org/10.1016/j.surg.2004.02.012.

Article  Google Scholar 

Toso C, Pinto Marques H, Andres A, Castro Sousa F, Adam R, Kalil A, Clavien PA, Furtado E, Barroso E, Bismuth H; Compagnons Hépato-Biliaires Group. 2017 Liver transplantation for colorectal liver metastasis: survival without recurrence can be achieved. Liver Transpl. 2017 Aug;23(8):1073–1076. https://doi.org/10.1002/lt.24791.

•• Tsilimigras DI, Sahara K, Hyer JM, Diaz A, Moris D, Bagante F, Guglielmi A, Ruzzenente A, Alexandrescu S, Poultsides G, Sasaki K, Aucejo F, Ejaz A, Cloyd JM, Pawlik TM. 2021 Trends and outcomes of simultaneous versus staged resection of synchronous colorectal cancer and colorectal liver metastases. Surgery. 2021 Jul;170(1):160–166. https://doi.org/10.1016/j.surg.2021.01.041. Study found that simultaneous resection was associated with increased morbidity; however, long-term survival was comparable between simultaneous and staged resection.

van Lienden KP, van den Esschert JW, de Graaf W, Bipat S, Lameris JS, van Gulik TM, van Delden OM. Portal vein embolization before liver resection: a systematic review. Cardiovasc Intervent Radiol. 2013;36(1):25–34. https://doi.org/10.1007/s00270-012-0440-y.

Article  Google Scholar 

Wang K, Liu M, Wang HW, Jin KM, Yan XL, Bao Q, Xu D, Wang LJ, Liu W, Wang YY, Li J, Liu LJ, Zhang XY, Yang CH, Jin G, Xing BC. Mutated DNA damage repair pathways are prognostic and chemosensitivity markers for resected colorectal cancer liver metastases. Front Oncol. 2021;31(11): 643375. https://doi.org/10.3389/fonc.2021.643375.

Article  Google Scholar